89 related articles for article (PubMed ID: 20471643)
21. Cyclin E Expression Correlates with Cancer-specific Survival in Endometrial Endometrioid Adenocarcinoma.
Santala S; Talvensaari-Mattila A; Soini Y; Santala M
Anticancer Res; 2015 Jun; 35(6):3393-7. PubMed ID: 26026100
[TBL] [Abstract][Full Text] [Related]
22. Association of mammalian target of rapamycin with aggressive type II endometrial carcinomas and poor outcome: a potential target treatment.
Peiró G; Peiró FM; Ortiz-Martínez F; Planelles M; Sánchez-Tejada L; Alenda C; Ceballos S; Sánchez-Payá J; Laforga JB
Hum Pathol; 2013 Feb; 44(2):218-25. PubMed ID: 22955108
[TBL] [Abstract][Full Text] [Related]
23. Epithelial to mesenchymal transition in early stage endometrioid endometrial carcinoma.
Montserrat N; Mozos A; Llobet D; Dolcet X; Pons C; de Herreros AG; Matias-Guiu X; Prat J
Hum Pathol; 2012 May; 43(5):632-43. PubMed ID: 21940036
[TBL] [Abstract][Full Text] [Related]
24. Gene expression profiling of microsatellite unstable and microsatellite stable endometrial cancers indicates distinct pathways of aberrant signaling.
Risinger JI; Maxwell GL; Chandramouli GV; Aprelikova O; Litzi T; Umar A; Berchuck A; Barrett JC
Cancer Res; 2005 Jun; 65(12):5031-7. PubMed ID: 15958545
[TBL] [Abstract][Full Text] [Related]
25. Microsatellite instability in endometrioid type endometrial adenocarcinoma is associated with poor prognostic indicators.
An HJ; Kim KI; Kim JY; Shim JY; Kang H; Kim TH; Kim JK; Jeong JK; Lee SY; Kim SJ
Am J Surg Pathol; 2007 Jun; 31(6):846-53. PubMed ID: 17527071
[TBL] [Abstract][Full Text] [Related]
26. Epidemiologic and surgicopathologic findings of papillary serous and clear cell endometrial cancers when compared to endometrioid carcinoma.
Cirisano FD; Robboy SJ; Dodge RK; Bentley RC; Krigman HR; Synan IS; Soper JT; Clarke-Pearson DL
Gynecol Oncol; 1999 Sep; 74(3):385-94. PubMed ID: 10479498
[TBL] [Abstract][Full Text] [Related]
27. FGF2 transcript levels are positively correlated with EGF and IGF-1 in the malignant endometrium.
Soufla G; Sifakis S; Spandidos DA
Cancer Lett; 2008 Feb; 259(2):146-55. PubMed ID: 18006148
[TBL] [Abstract][Full Text] [Related]
28. Stage II endometrioid adenocarcinoma of the endometrium: clinical implications of cervical stromal invasion.
Orezzoli JP; Sioletic S; Olawaiye A; Oliva E; del Carmen MG
Gynecol Oncol; 2009 Jun; 113(3):316-23. PubMed ID: 19345400
[TBL] [Abstract][Full Text] [Related]
29. Up-regulation of DNA methyltransferase 3B expression in endometrial cancers.
Jin F; Dowdy SC; Xiong Y; Eberhardt NL; Podratz KC; Jiang SW
Gynecol Oncol; 2005 Feb; 96(2):531-8. PubMed ID: 15661247
[TBL] [Abstract][Full Text] [Related]
30. Urokinase-type plasminogen activator resulting from endometrial carcinogenesis enhances tumor invasion and correlates with poor outcome of endometrial carcinoma patients.
Huang CY; Chang MC; Huang WY; Huang CT; Tang YC; Huang HD; Kuo KT; Chen CA; Cheng WF
Sci Rep; 2015 Jun; 5():10680. PubMed ID: 26033187
[TBL] [Abstract][Full Text] [Related]
31. Expression patterns of kinin-dependent genes in endometrial cancer.
Orchel J; Witek L; Kimsa M; Strzalka-Mrozik B; Kimsa M; Olejek A; Mazurek U
Int J Gynecol Cancer; 2012 Jul; 22(6):937-44. PubMed ID: 22706224
[TBL] [Abstract][Full Text] [Related]
32. Molecular profile of grade 3 endometrioid endometrial carcinoma: is it a type I or type II endometrial carcinoma?
Alvarez T; Miller E; Duska L; Oliva E
Am J Surg Pathol; 2012 May; 36(5):753-61. PubMed ID: 22498825
[TBL] [Abstract][Full Text] [Related]
33. [Expression of P53, P63, and C-erbB-2 in endometrioid adenocarcinoma and their clinicopathological significance].
Hu WF; Liu MQ; Zhao Q
Ai Zheng; 2004 Sep; 23(9):1021-5. PubMed ID: 15363194
[TBL] [Abstract][Full Text] [Related]
34. Increased epithelial stem cell traits in advanced endometrial endometrioid carcinoma.
Chang SJ; Wang TY; Tsai CY; Hu TF; Chang MD; Wang HW
BMC Genomics; 2009 Dec; 10():613. PubMed ID: 20015385
[TBL] [Abstract][Full Text] [Related]
35. Expression of tumor suppressor genes related to the cell cycle in endometrial cancer patients.
Witek Ł; Janikowski T; Bodzek P; Olejek A; Mazurek U
Adv Med Sci; 2016 Sep; 61(2):317-324. PubMed ID: 27218895
[TBL] [Abstract][Full Text] [Related]
36. [Endometrial cancer in young women--clinical and molecular aspects].
Lapińska-Szumczyk S; Supernat A; Żaczek AJ; Majewska H; Gulczyński J; Sawicki S; Biernat W; Wydra D
Ginekol Pol; 2014 Oct; 85(10):754-9. PubMed ID: 25546926
[TBL] [Abstract][Full Text] [Related]
37. PIK3CA missense mutation is associated with unfavorable outcome in grade 3 endometrioid carcinoma but not in serous endometrial carcinoma.
McIntyre JB; Nelson GS; Ghatage P; Morris D; Duggan MA; Lee CH; Doll CM; Köbel M
Gynecol Oncol; 2014 Jan; 132(1):188-93. PubMed ID: 24262879
[TBL] [Abstract][Full Text] [Related]
38. The FOXO1-miR27 tandem regulates myometrial invasion in endometrioid endometrial adenocarcinoma.
Mozos A; Catasús L; D'Angelo E; Serrano E; Espinosa I; Ferrer I; Pons C; Prat J
Hum Pathol; 2014 May; 45(5):942-51. PubMed ID: 24746199
[TBL] [Abstract][Full Text] [Related]
39. Integrated eicosanoid lipidomics and gene expression reveal decreased prostaglandin catabolism and increased 5-lipoxygenase expression in aggressive subtypes of endometrial cancer.
Cummings M; Massey KA; Mappa G; Wilkinson N; Hutson R; Munot S; Saidi S; Nugent D; Broadhead T; Wright AI; Barber S; Nicolaou A; Orsi NM
J Pathol; 2019 Jan; 247(1):21-34. PubMed ID: 30168128
[TBL] [Abstract][Full Text] [Related]
40. Lynch syndrome--related endometrial carcinomas show a high frequency of nonendometrioid types and of high FIGO grade endometrioid types.
Carcangiu ML; Radice P; Casalini P; Bertario L; Merola M; Sala P
Int J Surg Pathol; 2010 Feb; 18(1):21-6. PubMed ID: 19443869
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
